ads

ads

Thursday, 18 May 2017

Diabetes Drug Gets FDA Warning Due to Amputation Risk

Canagliflozin tied to a doubling of amputations of legs, feet, agency says

HealthDay news image

Source: HealthDay


via Diabetes
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)